Electronics & Semiconductor Manufacturers
NIIMBL: National Institute for Innovation in Manufacturing Biopharmaceuticals
590 Avenue 1743, Newark, DE 19713, United States · Manufacturing companies in Newark
About NIIMBL: National Institute for Innovation in Manufacturing Biopharmaceuticals
It is funded through a cooperative agreement with the National Institute of Standards and Technology (NIST) in the U.S. Department of Commerce, with additional support from its member organizations. The institute runs a structured solicitation process — Requests for Proposals, Information, and Applications — to fund technical projects in areas such as intelligent biomanufacturing, advanced process analytics, process intensification, and next‑generation biotherapeutic platforms. It also administers workforce initiatives including the NIIMBL eXperience for Educators and a Faculty Fellows sabbatical program. Its membership spans large and small biopharmaceutical companies, academic institutions, non‑profits, and government agencies. As of June 2023, industry partners represented 51 % of members, academia 30 %, non‑profits 16 %, and government 3 %. Member companies cited in testimonials include GlaxoSmithKline, AstraZeneca, and Bristol Myers Squibb. The institute serves the broader biopharmaceutical manufacturing ecosystem, including medical countermeasure development and biodefense. NIIMBL’s stated differentiators center on its public–private model that enables pre‑competitive collaboration, accelerates the translation of innovative manufacturing technologies, and strengthens domestic supply‑chain resilience. The organization aims to enhance U.S. economic security, increase global competitiveness, and bring life‑saving medicines to market faster.
Manufacturing capabilities
Core processes
- Collaborative biopharmaceutical manufacturing platform development
- Technology de-risking and adoption support
- Workforce training program administration (NIIMBL eXperience, Faculty Fellows)
- Project funding via RFP, RFI, RFA solicitations
- Advanced process analytics and real-time manufacturing control research
Industries served
- Biopharmaceutical manufacturing
- Biotechnology
- Pharmaceutical industry
- Medical countermeasures
- Biodefense
- Workforce development and education
Company details
- Location
- Newark, Delaware
Frequently asked questions
Where is NIIMBL: National Institute for Innovation in Manufacturing Biopharmaceuticals located?
NIIMBL: National Institute for Innovation in Manufacturing Biopharmaceuticals is located at 590 Avenue 1743, Newark, DE 19713, United States.
What does NIIMBL: National Institute for Innovation in Manufacturing Biopharmaceuticals do?
NIIMBL: National Institute for Innovation in Manufacturing Biopharmaceuticals is listed under Electronics & Semiconductor Manufacturers, and its listed capabilities and products include Collaborative biopharmaceutical manufacturing platform development, Technology de-risking and adoption support, Workforce training program administration (NIIMBL eXperience, Faculty Fellows), Project funding via RFP, RFI, RFA solicitations, Advanced process analytics and real-time manufacturing control research and Intelligent biomanufacturing through AI and digitalization.
What industries does NIIMBL: National Institute for Innovation in Manufacturing Biopharmaceuticals serve?
NIIMBL: National Institute for Innovation in Manufacturing Biopharmaceuticals lists Biopharmaceutical manufacturing, Biotechnology, Pharmaceutical industry, Medical countermeasures and Biodefense among the industries it serves.
How do I request a quote from NIIMBL: National Institute for Innovation in Manufacturing Biopharmaceuticals?
Use the Request a quote button on this page to send NIIMBL: National Institute for Innovation in Manufacturing Biopharmaceuticals your requirements through FirmsLedger, or visit niimbl.org.
What companies are similar to NIIMBL: National Institute for Innovation in Manufacturing Biopharmaceuticals?
Other Electronics & Semiconductor Manufacturers in Delaware listed on FirmsLedger include Creative Devices, Inc., Phase Sensitive Innovations and Center for Composite Materials (CCM).